Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of noscapine-containing products on COVID-19
IRCT20180103038199N3Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of noscapine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Mashhad University of Medical Sciences. Started Oct 2020; status: completed.
02
Drugs
noscapine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180103038199N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038199N3.